SEDA Experts LLC, a leading expert witness firm providing world-class financial expert witness services, announced today that Arvind Krishnamurthy joined the firm as Managing Director. New York, NY, Aug. 28, 2026 (GLOBE NEWSWIRE) — SEDA Experts LLC, a leading expert witness firm providing world-class financial expert witness services, announced today that Arvind Krishnamurthy joined the firm as Managing Director. “Arvind has experience across a range of alternative investment assets,” said Peter Selman, Managing Partner of SEDA Experts. Arvind Krishnamurthy is a private credit, private equity, specialty finance and alternative investments expert with nearly 30 years of experience originating, structuring, underwriting and managing complex investments across the capital structure, including income-generating niche assets such as...

The Nasdaq-listed AI company closes its MBody AI merger; adds $10 million to scale robot deployments with Fortune 500 enterprise customers ISFIYA, Israel and LAS VEGAS, Aug. 28, 2026 (GLOBE NEWSWIRE) — Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: MBAI), an embodied artificial intelligence company, announced today the completion of its business combination with MBody AI Corp. on August 26, 2026 (the “Merger”) and the closing of its firm-commitment underwritten public offering (the “Offering”) of 1,538,462 ordinary shares at a public offering price of $6.50 per share, before underwriting discounts and commissions, on August 27, 2026. In addition, the Company has granted the underwriter a 30-day option to purchase up to an additional 230,769 ordinary shares at the public offering price, less the underwriting discounts and...

Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth StrategyTeva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth StrategyBXCL501, a novel dexmedetomidine sublingual film, is under FDA review for potential at-home (outpatient) use for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.  Agreement is part of a court-supervised sale process with BioXcel Therapeutics, Inc. and remains subject to bankruptcy court approval, potential higher bids, and customary closing conditions.  Transaction reflects Teva’s targeted business development approach focused on strategic fit, patient needs, and potential...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree APTITUDE SOFTWARE GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: APTITUDE...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree GOOCH & HOUSEGO PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Pasqal Holding SA expects its ordinary shares to begin trading on Nasdaq under the ticker symbol “PSQL” on August 28th Transaction establishes a strong capital foundation for Pasqal as a public company, with approximately $360 million of cash available at closing to accelerate global quantum-system deployment, commercial adoption and Pasqal’s path toward fault-tolerant quantum computing Public listing creates a long-term capital platform for one of the world’s leading neutral-atom quantum computing companies PARIS and NEW YORK, Aug. 27, 2026 (GLOBE NEWSWIRE) — Pasqal Holding SA (“Pasqal”), a global leader in neutral-atom quantum computing, and Bleichroeder Acquisition Corp. II (NASDAQ: BBCQ), a special purpose acquisition company (“Bleichroeder”), today announced the successful completion of their previously announced business combination. Bleichroeder...

Transaction Strengthens First Financial’s Illinois Franchise Through Addition of Hickory Point Bank and Trust TERRE HAUTE, Ind. and DECATUR, Ill., Aug. 27, 2026 (GLOBE NEWSWIRE) — First Financial Corporation (NASDAQ: THFF) (“First Financial”), the holding company for First Financial Bank, N.A. (“First Financial Bank”), and First Illinois Corporation (“First Illinois”), the holding company for Hickory Point Bank and Trust (“Hickory Point Bank”), jointly announced today the execution of a definitive agreement under which First Illinois will merge with and into First Financial in a stock/cash transaction valued at approximately $111.3 million based on First Financial’s stock price of $79.07 on August 26, 2026. The transaction will complement First Financial’s existing Illinois franchise by adding Hickory Point Bank’s strong community...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. FOR FURTHER INFORMATION, PLEASE SEE SECTION ENTITLED “IMPORTANT INFORMATION” BELOW. S-Bank Plc has received required merger control clearance for its voluntary public cash tender offer for all the shares in Oma Savings Bank Plc OMA SAVINGS BANK PLC        STOCK EXCHANGE RELEASE        27.8.2026 at 9:05 a.m. (EEST) On 9 July 2026, S-Bank Plc (“S-Bank” or the “Offeror”), announced a voluntary recommended public cash tender offer for all the issued and outstanding shares in Oma Savings Bank Plc (“Oma Savings Bank”) that are not held by Oma Savings Bank or its subsidiaries (the “Shares”...

AUDUBON, Pa., Aug. 26, 2026 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the acquisition of Higgs Boson Health, a digital healthcare experience company based in Durham, NC and incubated out of Duke University. With a mission to transform healthcare experience through digital innovation, Higgs Boson will position Globus Medical to shape patient and provider experience throughout the full episode of care. “Higgs Boson employs highly experienced teams of software developers and AI scientists who will be joining our team to power our vision of a seamless digital healthcare environment to simplify a patient’s journey through our healthcare system while enhancing real-time information and surgical intelligence available to healthcare providers with the ultimate goal...